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Abstract 
Calcium oxalate (CaOx) crystallization in the pres-
ence of phosphocitrate (PC) was studied by both in vitro 
and in vivo techniques. Crystals of the monohydrate 
(COM) and the dihydrate (COD) forms were generated 
under controlled conditions in a silica gel matrix. Our 
data indicated only COD crystals formed when PC was 
present, inferring that the COD to COM transformation 
was being impeded. COD crystals were smaller in size 
than controls and there was evidence of interpenetral 
twinning. An in vivo study using a rat bladder implant 
model noted similar findings. Scanning electron micros-
copy (SEM) revealed that implants recovered from PC 
treated rats had primarily COD crystals deposited, 
whereas both the surface and inner layers of encrusted 
implants from normal rats contained predominantly 
COM crystals. Infrared (IR) analysis confirmed the 
visual findings indicating quantitatively that there was a 
higher proportion of COD present on the implants recov-
ered from the treated rats than in the controls. It is con-
cluded that although total CaOx crystallization cannot be 
eliminated by PC, its action could assist in reducing the 
harmful nature of such crystallites in the urine. 
Key Words: Phosphocitrate, crystal morphology, cal-
cium oxalate monohydrate, calcium oxalate dihydrate, 
inhibition, gel matrix, bladder implant calculi. 
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The influence of both small and macromolecular in-
hibitors of the nucleation and growth of urinary crystal-
lites has been widely reported together with speculation 
of their mechanisms of action (Pak et al., 1975; Toma-
zic and Nancollas, 1980; Coe et al ., 1991; Nancollas et 
al., 1991; Tiselius et al., 1993). Some compounds 
naturally display more inhibitory power than others, a 
characteristic which appears to relate to a number of 
functions including ionic charge, size, stereochemistry 
and the compound's relationship to the changing face of 
growing crystals (Williams and Sallis, 1982) . 
Phosphocitrate (PC) is a compound with no known 
toxic side effects and with a strong inhibitory action 
against the crystallization of hydroxyapatite, calcium 
oxalate (CaOx) and mixed stone phosphate salts (Tew et 
al., 1980; Williams and Sallis, 1982; Brown and Sallis, 
1983; Shankar et al., 1984; Sallis et al., 1989; Achilles 
et al., 1990). To date, however, very few data have 
been accrued on the nature of PC-crystal interface inter-
actions. On the basis of reported morphological changes 
to crystals in the presence of other weaker inhibitors 
(Martin et al., 1984; Marickar and Koshy , 1987), it 
might be predicted that crystal habit should be changed 
by PC. Certainly, a reduction in CaOx monohydrate 
(COM) particle size as demonstrated by the constant 
composition technique is known to occur (Richardson et 
al ., 1990), and it has also been found that PC exhibits 
a strong surface binding affinity, much more so than is 
seen for example with citrate. Such data then have en-
couraged us to look at crystal habit of both the dihydrate 
and monohydrate forms of CaOx, as influenced by PC. 
Growing crystals in vitro in the presence of inhibi-
tors in a gel medium is one technique for studying their 
changing morphology. LeGeros and Morales (1973) and 
Marickar and Koshy (1987) have previously reported 
their observations on CaOx, brushite, and mixed stone 
crystallization. Techniques such as scanning electron 
microscopy (SEM), infrar ed (IR) analysis and X-ray 
diffraction, can then be applied to reveal more detailed 
structural, morphological and compositional aspects of 
J.D . Sallis et al. 
the crystals. Whilst an in vitro gel system is regarded 
as generating reliable and useful information and can do 
so under well defined growth conditions, confirmation of 
the findings needs to be followed up in vivo where the 
nature of the environment is much more complex. One 
animal model which we and others have used effectively 
(Khan et al.; 1984, Khan and Hackett, 1985a; Sallis et 
al., 1988) is based upon an original study by Vermeulen 
et al. (1950). The model involves the implantation of a 
foreign body into the bladder of a rat to act as a nucleus 
for crystal growth. Khan et al. (1984) implanted a poly-
meric disk as the foreign body to provide later advant-
ages in SEM examination of encrusted disks. Their 
studies have included morphological, kinetic and growth 
patterns of CaOx crystal formation under hyperoxaluric 
conditions (Khan et al., 1984; Khan and Hackett, 1985a, 
1985b). 
In the current studies, we describe the morphologi-
cal and growth changes to COM and CaOx dihydrate 
(COD) crystals brought about by the presence of PC. 
Data obtained from an in vitro gel matrix system have 
been compared to changes observed when crystals are 
grown on polymer implants in the bladder of rats. Anal-
ysis by SEM and IR has provided evidence of the nature 
and extent of these changes when influenced by PC. 
Materials and Methods 
PC was prepared by phosphorylation of triethyl or 
tribenzyl citric acid using methods previously reported 
(Tew et al., 1980; Williams and Sallis, 1980; Pankowski 
et al., 1994). Following deprotection of the phospho-
rylated intermediate through hydrogenation and base hy-
drolysis, the sodium salt of PC was crystallized from 
water. The compound was assayed and characterized by 
our earlier reported techniques (Williams and Sallis, 
1980). 
Preparation of gels containing COM and COD 
crystals 
Silicate gels were prepared essentially as described 
by Marickar and Koshy (1987). Sodium metasilicate 
(density = 1.03) was rapidly adjusted to pH 6 with ace-
tic acid (3 M) before pouring into 12 mm diameter U 
tubes, each limb being 150 mm high. Once set, COM 
crystals were formed by pouring 5 ml sodium oxalate 
(NaOx) solution (1 M) in the left limb and 5 ml calcium 
chloride (1 M) in the right limb of the U tube. Con-
ditions for concurrent COM and COD nucleation and 
growth were established by pouring NaOx (1 M) into the 
left limb and an equal quantity of a mixed solution of 
CaC12 (1 M) and magnesium acetate (1 M) into the right 
limb. Conditions for COD development were estab-
lished when part of the CaC12 solution used for the 
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COM preparation above was replaced by MgC12 , giving 
a Ca2 +:Mg 2 + ratio of 3: 1 (LeGeros and Morales, 
1973). PC was dissolved in the metasilicate solution 
prior to setting, to give final concentrations of either 560 
µMor 2.2 mM. 
Production of epoxy resin implants 
A modification to the method described by Khan et 
al. (1984) was used to manufacture hemispherical disks 
of epoxy resin. An homogeneous mixture of vinyl cy-
clohexene dioxide (10 g), nonenylsuccinic anhydride (26 
g) and diglycidyl ether of polypropylene glycol (6 g) was 
prepared to give an epoxy resin of medium hardness. 
This was left for 10-15 minutes with constant stirring, 
care being taken to avoid bubbles. Dimethyl aminoeth-
anol (0.4 g) was then added to harden the mixture, and 
the final product used within 24 hours. 
Lead mould impressions were made using glass 
beads pressed firmly between two lead sheets. A 12 µ1 
portion of the epoxy resin mixture was pipetted into each 
impression in the lead plates, and polymerization was 
achieved at 60-70°C over 8 hours. The formed disks 
were released from the moulds and polished with fine 
sandpaper. They were 4 mm in diameter, with an aver-
age mass of 13.5 mg. The finished product proved suit-
able for insertion without damage to the bladder. 
Experimental regime 
In all in vivo experiments, male Hooded Wistar rats 
(240-260 g) were used . The surgical procedure was 
similar to that described by Vermeulen et al. (1950) and 
as we have previously reported (Sallis et al., 1988). All 
surgical instruments were steam sterilized between oper-
ations, and the implants presoaked in 70 % isopropanol. 
Rats were anaesthetized with halothane-oxygen (1.5 % 
halothane, oxygen flow rate: 300 cm3 /min), and 70 % 
isopropanol and 0.5 % Hibitane (ICI Australia, Ltd.), re-
spectively, were swabbed onto the fur and skin site be-
fore making an external suprapubic incision . A small 
incision at the proximal end of the exposed bladder en-
abled the implant to be inserted. The bladder and body 
wall incisions were then closed with silk sutures, and the 
external wound closed with cotton sutures and swabbed 
with Panolog ointment (E.R.Squibb and Sons, Pty . Ltd. , 
Victoria, Australia) . No additional antibiotic treatment 
was required as in our experience, and indeed others 
(Khan and Hackett, 1985b), urinary tract bacterial infec-
tions never developed. Following a 24 hour recovery 
period, the rats were placed on an hyperoxaluric diet 
(day 1) comprising normal rat chow premixed to contain 
1 % added glycolate. 
Daily doses (9:30 a.m. and 4:30 p.m.) of PC were 
administered from day l by intraperitoneal (ip) adminis-
tration, at a dose rate of 250 mg PC/kg body weight/ 
day. Sustained administration at this level does not 
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Figure 1. Characteristic morphologie s of COM and 
COD crystals formed in silicate gel in the presence or 
absence of PC, under COM growth conditions. (a). 
Control. (b) . PC (560 µM). (c) . PC (2 .22 mM). 
Bars = 100 µm . 
induce changes to urinary parameters (Sallis et al., 
1988). Rats were divided into a control group (13 rats) 
and a treated group (12 rats), the controls receiving a 
placebo injection of 0 .9 % saline and handled in a like 
manner. Termination of the experiment occurred on day 
28, when the rats were sacrificed, and the implanted 
discs recovered from the bladder. Immediately upon re-
moval, the crystal encrusted implants were placed in a 
desiccator and dried with silica gel as the desiccant. 
Scanning electron microscopy 
Stone samples (as above) were mounted on stubs (13 
mm diameter) with double-sided adhesive tape and 
coated with high-purity gold before being examined by 
SEM , using a Philips SEM 505 analyzer. 
Infrared analysis of stone crystalline composition 
IR spectra were registered between 4000 cm-1 and 
500 cm-1 on a Digilab FTS-20E Fourier transform infra-
red spectrometer (USA). Crystal material was carefully 
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Figure 2. Characteristic morphologies of COD crystals 
formed in silicate gel in the presence or absence of PC, 
under COD growth conditions. (a) . Control. (b). PC 
(2.22 mM). Bars = 100 t,lm, 
this material was compressed with KBr to form a pellet 
( disk) under vacuum. 
Standard COM and COD crystals were prepared by 
the method of Grases et al. (1990). COM was prepared 
by adding 250 ml each of 7.5 mM NaOx and 7.5 mM 
CaC12 solutions simultaneously over 1 hour to 7 liters of 
distilled water heated to 70°C. The slurry so formed 
was then filtered, and the remaining crystals washed 
with water and ethanol, before being vacuum dried for 
24 hours at 50°C. Preparation of the COD crystals 
involved adding 50 ml of CaC12 (0.25 M) dropwise to a 
200 ml solution containing NaH2PO4 (43.6 mM), 
NazHPO 4 (6.1 mM), NaCl (0.23 M), trisodium 
citrate.2H 2O (3.9 mM), Na2SO4 (34.2 mM), 
MgSO4.7H2O (5.9 mM), NH4Cl (86.7 mM), KCI (0.16 
M) and NaOx (1.9 mM). This solution was continuous-
ly stirred in an ice bath ( 4 °C) for 1 hour. The slurry 
was then filtered and the crystals washed with water and 
absolute ethanol. 
KBr pellets of COM and COD standards were ana-
lyzed by IR to provide reference spectra for the stone 
material obtained in the bladder. The percentage COD 
present in a deposit on an implant was calculated from 
its IR spectra using the regression equation of Martin et 
al. (1984): 
y = 302 · 1 x R - 11.9 (1) 
where y is the fractional content in percentage of COD 
in the sample, and R is the ratio of the absorbances at 
910 and 780 cm-1. 
Results 
In vitro gel system 
Growth of crystals within the gels in less than 48 
hours was sufficient for observation by light microscopy 
(Figs. 1-3). Under the specified pH and growth condi-
tions and in the absence of PC, crystals of predicted type 
were produced. Coffin-lid shaped crystals were 
observed under pure COM and COM/COD growing 
conditions (Figs. la and 3a), whilst the COD crystals 
under growth conditions generating either pure COD or 
a mixture of COM/COD (Figs. 2a and 3a) were distinct 
dipyramidal tetrahedral structures. 
When PC (2.22 mM) was included in the gel, COM 
crystals were noticeably absent under all three growing 
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Figure 3. Characteristic morphologies of COM and 
COD crystals formed in silicate gel in the presence or 
absence of PC, under COM and COD growth condi-
tions. (a). Control. (b) . PC (560 µM) . (c). PC 
(2.22 rnM). Bars = 100 µm. 
conditions. Even under COM or COM/COD growth 
conditions, typical dipyrarnidal COD crystals formed 
(Figs. le and 3c) . At a lower PC concentration (560 
µM), COM crystal formation (Figs . lb and 3b) was still 
impaired and COD crystals showed signs of interpene-
trant twinning and mulberry-shaped morphologies. 
Foreign body implantation model 
Rats receiving the implants remained healthy during 
the experimental period , displaying normal weight gain 
and food and water consumption. Figure 4 compares an 
implant disk prior to insertion (Fig. 4a) with an implant 
(now heavily encrusted with crystallite material) re-
moved four weeks later from a control rat (Fig. 4b). 
Crystallite deposition was strongly evident in both 
treated and control groups. No additional crys tal mate-
rial (i.e., daughter stones) was found within the bladders 
of either the control or PC treated rat groups. 
No significant differenc e in the amount of material 
accumulating on the implants between the control and 
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Figure 4 (at top). Scanning electron micrographs of polymeric epoxy resin implant. (a). Implant before insertion . 
Bar = 1 mm. (b). Implant after insertion . A profile of the encrusted material is shown. Bar = 1 mm. 
Figure 5. Surface crystals of stone material growing on implants after 28 days . (a) . Surface of encrusted implant 
removed from control rat. Bar = 100 µm . (b) . Surface of encrusted bladder implant from rat treated with PC. Bar 
= 10 µm . 
Table 1. Depo sition of CaOx on bladder implants in control rats and in rats receiving PC . 
Time (days) 
0 28 
Rat Group Implanted Disk Removed Disk Mass of 
Mass (mg) Mass (mg) Deposit (mg) 
Control 13.91 ± 1.77 31.57 ± 15.10 17.66 ± 15.24 
(n = 13) 
PC (n= 12) 13.74 ± 1.96 31.18 ± 8.87 17.34 ± 8.45 
250 mg/kg/day 
Rats were fed a normal chow diet supplemented with 1 % glycolic acid for the 28 day experimental period . 
Values are shown as mean ± 1 standard deviation (S.D .). n = number of animals used. 
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Table 2. The proportion of COD present in stones re-
moved from control and PC treated animals (values are 
shown as mean ± 1 S.D. ; n = number of samples). 
Group 
Control (n = 3) 
PC Treated (n = 5) 
(250 mg/kg body weight/day) 
• p = 0.0097 (Student's t-test) . 
% COD in Sample 
34.84 ± 3.11 
75.65 ± 18.20* 
PC treated groups was evident (Table 1). When the en-
crusted material was viewed initially under the light 
microscope, distinct crystals were more numerous on the 
implants from the PC treated rats than from the controls. 
Under SEM analysis (Fig. 5), COM crystals were 
prominent on the implants from control rats, being typi-
cally smooth-surfaced coffin-lid shaped , approximately 
100 µ.m in length . Disks removed from rats receiving 
PC however, revealed surface crystals of COD (small, 
about 10-20 µ.m) of tetrahedral , dipyrimidal habit (Fig. 
Sb). No COM crystals were present on the implant 
surface. 
Infrared analysis 
Spectral profiles obtained with synthetic COM and 
COD (not shown here) were identi cal to those previously 
well docum ented in the literature (e.g., see Martin et 
al. , 1984; Oka et al., 1985) . Characteristic spectra l ab-
sorption peaks for COM were as follows : a sharp peak 
at 780 cm-1 (maximum absorbance about 65%), a medi-
um-broad peak at 640 cm-1 (30 % ) and a smaller peak at 
590 cm-1 (15 % ). The presence of a small, broad peak 
at 780 cm-1 (maximum absorbance 20%) was evidence 
for COD. 
The fraction of COD present on the recovered im-
plants, assessed as described in the methods , is shown in 
Table 2. COD was a minor componen t of the deposits 
in the controls whereas, crystalline material from the PC 
treated animals was predominantly COD. 
Discussion 
PC , when present in vitro or in vivo during the gen-
eration of COM and/or COD, exerts a marked inhibitory 
influence on the formation of the two crystalline types. 
Responses to the inhibitor are not however identical. 
Crystal habit of the COD produced under our in vivo 
trials did not change. Although phase transformation 
was not examined per se , it is apparent from the mor-
phological evidence that PC prevented the transformation 
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from COD to COM , although a direct role in preventing 
any concurrent COM nucleation cannot be discounted. 
Calcium oxalate phase changes have been investi-
gated by a number of researchers who have considered 
dissolution and recrystallization rates, as well as solubili-
ty and zeta potentials of COM and COD (Tomazic and 
Nancollas, 1980; Lepage and Tawashi , 1982; Leusmann 
et al., 1984). In the presence of an inhibitor such as 
polyphosphate, for example, the data strongly indicate 
that dissolution of COD is implicitly controlled by a 
surface phenomenon. It is not surprising then that PC, 
a molecule possessing several dissociable groups leading 
to a strong negative charge and a known strong affinity 
for calcium salt crystal surfaces (Richardson et al., 
1990) should affect COD in the manner observed. 
Whilst the typical dipyramidal COD shape was still evi-
dent with PC present (Figs. 2 and 4), fractured forms of 
twinned dipyramid s were also observed in vitro (Fig. 3), 
giving further evidence for the notion that the PC was 
stabilizing the initial formation of the COD. Kim (1982) 
has previously reported such a twinning phenomenon. 
Martin et al. (1984) from in vitro studies have similarly 
concluded that the inhibitors citrate and pyrophosphate, 
increase the prevalence of COD by phase stabilization , 
thus , preventing COD to COM transformation. Another 
feature of PC influence was the visual observation that 
a smaller sized crysta l of COD was produced. This 
probably reflects a slower rate of crys tal generation and 
maturation, an obvio us benefit in ultimately passaging 
such immatur e crystallit es through the urinary tract. 
The inhibition of COM formation and growth in the 
presence of PC was also clearly evident in vitro. At 
both concentrations of PC tested, COM formation was 
completely eliminated. This finding taken together with 
the knowledg e that PC has the ability to disperse COM 
crysta ls (Richardson et al ., 1990), makes the compound 
a very useful inhibitor. 
SEM of the implanted polymer disks revealed a pic-
ture of crystal deposition and growth similar to that de-
scribed by Khan and Hackett (1985b). In their studies , 
they observed COM crysta ls as being present throughout 
a CaOx urinary stone from its base to the periphery 
(Khan and Hackett, 1993). Iwata et al . (1992) observed 
that within a CaOx stone, the COM component is mainly 
found throughout the inner layers, whilst the more 
prominent COD is present near the surface. In our stud-
ies , those rats not receiving PC had poor definition of 
crystalline shape in the inner layers next to the disk sur-
face, suggestive of the monohydrate form , with some 
COD crystals clearly evident on the surface. More nu-
merous and prominent crystals of COD however , were 
evident in those rats treated with PC with some crystals 
penetrating deep into the inner layers (Fig. 4). The 
qualitative observations from the SEM study were con-
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firmed through the quantitative IR analysis, whereby less 
COD (35 % ) was found on the implants from the untreat-
ed rats to that in the PC treated (7 6 % ) . This is new 
data with regard to PC action on CaOx , and is in ac-
cordance with that found in other CaOx inhibitor studies 
(Martin et al., 1984). The amounts of PC actually 
transiting the urinary tract are unknown at present due 
to the lack of sensitive and specific methods to detect 
low concentrations of PC in tissue and fluids. 
It might be suggested that in vivo, responses to PC 
are a reflection of breakdown of the compound to its 
components, citrate and phosphate . This idea however 
is not tenable for several reasons. There is no evidence 
of strong hydrolytic degradation of PC in vivo and in 
previous studies (Williams and Sallis, 1980; Sallis et al., 
1988, 1991), we have demonstrated that equivalent con-
centrations of citrate or phosphate do not mimic the inhi-
bition observed with PC. Further, and of considerable 
interest, Richardson et al. (1990) have reported that cit-
rate can actually potentiate the inhibitory activity of PC . 
In summary, the inhibitory properties of PC toward 
formation and growth of CaOx crystals have been dem-
onstrated in vitro using a simple gel matrix system and 
the observations confirmed in vivo using the more com-
plex environmental conditions present in the rat model. 
As a possible useful therapeutic drug then , PC appears 
to offer potential. It cannot be stated though that PC or 
any other inhibitory compound is capable of totally pre-
venting CaOx crystallites from forming. If the re-
sponses seen here are considered in totality, then the 
inhibitor does offer the compromise of restraining crysta l 
formation and limiting growth size so that the prevailing 
crystallites have a chance of being eliminated safely in 
the urinary tract. The known greater rate of dissolution 
and slower growth of COD compared to COM (Tomazic 
and Nancollas, 1980), together with the formation of a 
smaller sized crystal in the presence of an inhibitor , 
would assist in their earlier elimination. Clearly, the 
rate of urinary excretion would also be an important fac-
tor. The correlation of data derived from experimentally 
induced stone models to that of clinical human urolithia-
sis findings is quite considerable on the evidence cited 
by Khan et al. (1984) and Khan and Hackett (1985a, 
1985b). Therefore, a therapeutic role for PC in post-
operative management of patients with a history of stone 
recurrence might be a future consideration. 
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Discussion With Reviewers 
H-G. Tiselius: High concentrations of calcium and 
oxalate were apparently added to the system. Which 
were the approximate solute concentrations or the cal-
cium oxalate supersaturation at the place of crystal 
nucleation? 
Authors: Concentrations of individual species were not 
assessed at the interface where crysta ls were nucleating 
and growing and indeed would be extremely difficult to 
measure. In the contex t of the goal of the experiment, 
supersaturation of the ionic species in question must 
have been achieved because the crystallite morphology 
was clearly expressed and reproducible under the re-
spective media condition s. 
W. Achilles: In the silica-gel model used in this work, 
concentration s of Ca and oxalate are applied at high, un-
physiological concentrations (each lM). Can the effect 
on crys tal morphology described in this paper also be 
observed in gel models which simulate physiological 
conditions better than done here? 
A.L. Rodgers : Would it be possible to use real urine 
(human or rat) in the in vitro experiments instead of 
aqueous solutions? The advantages of doing so in terms 
of the model 's credibility are obvious. 
H.-G. Tiselius : Is it the authors' experience that crystal 
nucleation in a gel system of this kind is superior to the 
nucleation in a solution in terms of reproducibility? 
Authors: Although morphology has not been described, 
it is known that PC can inhibit growth of oxalates in gels 
under conditions more closely mimicking those occur-
ring physiologically (Achilles et al., 1990) . Further, it 
has been demonstrated that crystal growth in gels in the 
presence of urine provides a similar profile (Marickar 
and Koshy , 1987) . A gel system is not necessarily supe-
rior but a useful alternative to other systems because the 
morphology of single crystals can be better observed . 
In the present study, we were concerned to document the 
action of a single inhibitor (PC), uncomplicated by the 
presence of extraneous promoters or inhibitors. 
A.L. Rodgers: Why did you choose to use an implant, 
as opposed to simply examining the crystalluria after 
J .D. Sallis et al . 
inducing the latter with a hyperoxaluric diet? What are 
the advantages of the implant model? 
Authors: Crystalluria measurements are short-term ob-
servations which are not conducive to observing the 
longer period required for development of calculi . The 
implant model is a more appropriate option as it is possi-
ble to quantify and simultaneously observe the morphol-
ogy of the precipitating crystallites. Foreign body stones 
are known to have a similar morphology to human uri-
nary stones (Khan and Hackett, 1985b). 
F. Grases: PC was supplied to the rats by intraperito-
neal administration, using high doses. What amount 
would be necessary to administer orally to produce the 
same effects? 
Authors: Quantitation of PC at a calcified site is cur-
rently beyond our technical capabilities. From in vitro 
experiments, we know the inhibitory concentration re-
quired to be effective is very low. In the light of prob-
able general tissue and fluid distribution when PC is 
given via the ip route, the amount administered therefore 
is not considered to be high. Oral bioavailability of PC 
is poor [Cooper CM, Sallis JD (1993). Studies on the 
gastrointestinal absorption of phosphocitrate, a powerful 
controller of hydroxyapatite formatio:i. Int J Pharm 98: 
165-172). Consequently, specific site directed prodrugs 
of PC to improve transport and general wastage are cur-
rently being prepared and tested. 
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F. Grases: How do the authors explain that in spite of 
detecting low crystalline deposits in the PC treated rats, 
no significant difference between the control and PC 
treated group in the total amount of accumulated mate-
rial on the implants was detected? 
H.-G. Tiselius: The in vivo experiments clearly show 
a lack of difference in the amount of precipitate (Table 
1) and the crystals shown in Figures 1 and 3 suggest a 
greater volume of the individual crystals with PC than 
without. How would you explain the beneficial effects 
of PC in calcium oxalate stone formation? 
Authors: We are unable to offer a data-based explana-
tion as to why there was no discernible difference in the 
mass of deposited material in either the control or 
treated groups. It is probable that the concentration 
ratios of inhibitor/ionic species for formation and growth 
of the crystals would need to be maximal over a 24 hour 
period if discernibl e weight differen ces were to become 
evident. The pharmacokinetic profile of PC is unknown 
at the present time. 
